BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Clinical Oncology

The World Journal of Clinical Oncology (WJCO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of oncology.  It was launched on November 10, 2010 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage oncologists worldwide to submit manuscripts to the WJCO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJCO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJCO’s acceptance rate: 55%. Submit here >>

2019 Published Issues
2 1
Editors-in-Chief
  • Hiten RH Patel, BM BCh, BSc, FRCS (Hon), PhD, Professor, Surgical Oncologist, (Email: hrhpatel@hotmail.com) Department of Urology, University Hospital North Norway (UNN), Tromso 9038, Norway
Indexing/Abstracting
The WJCO is now abstracted and indexed in PubMed, PubMed Central, Emerging Sources Citation Index (Web of Science), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and Superstar Journals Database.
Journal Metrics
IPP (Impact per Publication) (2015): 3.306; SNIP (Source Normalized Impact per Paper) (2015): 1.241; CiteScore (2016): 4.00.
ISSN
2218-4333 (online)
Editorial
Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide 
Antonio Braga, Paulo Mora, Andréia Cristina de Melo, Angélica Nogueira-Rodrigues, Joffre Amim-Junior, Jorge Rezende-Filho, Michael J Seckl 
World J Clin Oncol 10(2):28-37. Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.28
Minireviews
Oligometastases in prostate cancer: Ablative treatment 
Amalia Palacios-Eito, Amelia Béjar-Luque, Milagrosa Rodríguez-Liñán, Sonia García-Cabezas 
World J Clin Oncol 10(2):38-51. Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.38
Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy 
Ozkan Kanat, Hulya Ertas 
World J Clin Oncol 10(2):52-61. Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.52
Rational-emotive behavioral intervention helped patients with cancer and their caregivers to manage psychological distress and anxiety symptoms 
Chiedu Eseadi 
World J Clin Oncol 10(2):62-66. Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.62
Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms 
Yuichi Torisu, Kazuki Takakura, Yuji Kinoshita, Yoichi Tomita, Masanori Nakano, Masayuki Saruta 
World J Clin Oncol 10(2):67-74. Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.67
Retrospective Cohort Study
Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer 
Madeline Devaux, Laura Gerard, Corentin Richard, Leila Bengrine-Lefevre, Julie Vincent, Antonin Schmitt, François Ghiringhelli 
World J Clin Oncol 10(2):75-85. Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.75
Retrospective Study
Impact of conditioning regimen on peripheral blood hematopoietic cell transplant 
Michael Burns, Anurag K Singh, Carrie C Hoefer, Yali Zhang, Paul K Wallace, George L Chen, Alexis Platek, Timothy B Winslow, Austin J Iovoli, Christopher Choi, Maureen Ross, Philip L McCarthy, Theresa Hahn 
World J Clin Oncol 10(2):86-97. Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.86
Observational Study
Hong Kong female’s breast cancer awareness measure: Cross-sectional survey 
May Pui Shan Yeung, Emily Ying Yang Chan, Samuel Yeung Shan Wong, Benjamin Hon Kei Yip, Polly Suk-Yee Cheung 
World J Clin Oncol 10(2):98-109. Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.98